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Dear editor
We have read with interest the comments from Orrico-Sánchez et al1 regarding our
recent paper on extraintestinal features of rotavirus (RV) infection.2 Their main
concerns relate to the section dealing with the potential of RV vaccines to decrease
hospitalizations due to seizures, and more specifically, the issues we raised in
regards to their non-significant findings that might have been caused by the use
of an overfitted statistical model.3 As our article was a general review beyond the
relationship between RV and seizures, we did not have room for detailed explana-
tions. We now take the opportunity to address Orrico-Sánchez et al's concerns.3
Contrary to what we stated in our recent paper,2 Orrico-Sánchez et al1 indicated that
their original publication3 did not include primary care cases but only convulsion-
related hospitalizations (ICD-9CM code 780.3).We apologize for this confusion which
was caused by our misunderstanding of the authors’ description in their paper: “All
primary care visits and hospitalizations are recorded in clinical databases”.3
We take issue, however, with the other comments by Orrico-Sánchez et al1
which are at least imprecise, if not incorrect. First, in our review2 we simply
mentioned the different methodology employed by Orrico-Sánchez et al3 based
on using absolute frequencies as a possible reason that might help explain their
contrasting findings when compared to those in other studies. This does not qualify
as a criticism.1 In fact, in our recently submitted study on seizures and RV vaccine
we also considered absolute frequencies and took into account population size as
covariate. Having said this, a remarkable difference between our analyses (in our
previous paper4 and in the one submitted) and those carried out by Orrico-Sánchez
et al,3 is that we showed detailed information on hospitalization rates by year, while
this information was fully omitted in their study.3 Not showing hospitalization rates
can be problematic; thus, the readers are left in the dark because they cannot
observe the different behaviors (eg, evolution over time) in hospitalization rates
in their targeted cohort (Region of Valencia; Southeast Spain). In addition, the data
shown by Orrico-Sánchez et al3 did not show key findings from their statistical
model; thereby their Table 3 did not show the effect of important variables, time in
months from the start of the observation period, time from vaccine's licensure, and
seasonality as the month of the year.
Second, our review2 indicated that the multiple regression model used by Orrico-
Sánchez et al3 used a number of redundant variants, which could have led to an
overfitting of their regression model. In our view, the arguments given by the authors1
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to support this decision are questionable, if not incorrect. To
start with, they indicated2 that controlling by confounders
eliminated a non-adjusted significant association between
RV vaccination and a reduction of seizure-related
hospitalizations.3 Turning this argument around, however,
it could be argued that an overfitted model could instead
foster undesirable false negative findings. Most noticeable
is the fact that the model proposed by Orrico-Sánchez et al3
included several variables that are intimately associated
with vaccines, including vaccination coverage, time from
vaccine licensure, and months from the start of the observa-
tion (eg, at the beginning of the study there was no vaccine,
and as time went by the vaccination coverage will have
increased). The use of these variables in a regression
model is highly redundant, thus causing multi-collinearity,
auto-correlation, statistical noise, and a lack of statistical
power. The withdrawal of RV vaccination in 2010 alone
does not justify the use of redundant variables1 because
such circumstance could even have contributed to
a decrease (or at least not an increase) in vaccination cover-
age. A better strategy to deal with the risk of collinearity
may have been to consider infant vaccination coverage as
the unique covariable related to RV vaccine.
Much has been written with regard to the unsuitability of
redundancy in regression models in general (eg, Yoo et al's
study)5, and more specifically in the field of vaccines. For
instance, the recent article byXu et al6 on vaccine safety points
out that “[. . .] redundant risk factors significantly reduce the
empirical power for detecting the association between the true
risk factors and the outcome [. . .]”, and that “[. . .] correctly
specifying the form of the relationship between risk factors
and the outcome is crucial”. Additional studies have argued in
the same direction, recommending to check for collinearity
before incorporating variables in the regression model,7 while
other authors propose the use of alternative methodologies
such as principal component analysis.8
Finally, our recently submitted article, which uses
negative binomial regression for hospitalization rates con-
sidering covariables such as gender, age, population size,
and month, does show clear significant results for “all
kinds of seizures” and convulsions related to vaccine cov-
erage (as shown in Figure 2 of our paper)2 in the Galician
population (Northwest Spain), thus further supporting our
initial findings.4
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